Federal Rulemaking

Federal Rulemaking

Improvements Needed to Monitoring and Evaluation of Rules Development as Well as to the Transparency of OMB Regulatory Reviews : Report to the Chairman, Committee on Oversight and Government Reform, House of Representatives

Website or Online Data - 2009
Rate this:
Regulation is one of the principal tools that the government uses to implement public policy. As part of the rulemaking process federal agencies must comply with an increasing number of procedural and analytical requirements. GAO was asked to examine how broadly applicable rulemaking requirements cumulatively have affected (1) agencies' rulemaking processes, in particular including effects of requirements added to the process since 2003, and (2) transparency of the Office of Information and Regulatory Affairs (OIRA) regulatory review process. To address these objectives, GAO reviewed selected rules issued between January 2006 and May 2008 and associated dockets and also interviewed knowledgeable agency and OIRA officials. GAO recommends that, consistent with internal control standards, the Environmental Protection Agency (EPA), Food and Drug Administration (FDA), and Securities and Exchange Commission (SEC) track and evaluate actual performance versus targeted milestones for developing significant rules to identify process improvement opportunities. GAO also recommends that OMB should provide additional guidance to agencies to improve transparency and documentation of the OIRA review process.


From the critics

Community Activity


Add a Comment

There are no comments for this title yet.


Add Age Suitability

There are no ages for this title yet.


Add a Summary

There are no summaries for this title yet.


Add Notices

There are no notices for this title yet.


Add a Quote

There are no quotes for this title yet.

Explore Further

Subject Headings


Find it at CPL

To Top